» Authors » Michael Peyrol

Michael Peyrol

Explore the profile of Michael Peyrol including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 432
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
de Groote P, Thuny F, Blanchart K, Gueffet J, Habib G, Salvat M, et al.
Arch Cardiovasc Dis . 2024 Sep; 117(11):624-632. PMID: 39317620
Background: Previous studies have demonstrated the benefit of a haemodynamic-guided management strategy with the CardioMEMS™ HF System. No data from French patients have been published. Aims: To analyse the feasibility,...
2.
Cautela J, Zeriouh S, Gaubert M, Bonello L, Laine M, Peyrol M, et al.
J Immunother Cancer . 2020 Dec; 8(2). PMID: 33298621
Background: Myocarditis is a rare but life-threatening adverse event of cancer treatments with immune checkpoint inhibitors (ICIs). Recent guidelines recommend the use of high doses of corticosteroids as a first-line...
3.
Rosier L, Zouaghi A, Barre V, Martins R, Probst V, Marijon E, et al.
J Clin Med . 2020 Apr; 9(3). PMID: 32244983
Acute myocarditis is associated with cardiac arrhythmia in 25% of cases; a third of these arrhythmias are ventricular tachycardia (VT) or ventricular fibrillation (VF). The implantation of a cardiac defibrillator...
4.
Baptiste F, Cautela J, Ancedy Y, Resseguier N, Aurran T, Farnault L, et al.
Open Heart . 2019 Jun; 6(1):e001049. PMID: 31168393
Objective: Atrial fibrillation (AF) is one of the most common side effects of ibrutinib, a drug that has dramatically improved the prognosis of chronic B-cell malignancies such as chronic lymphocytic...
5.
Sportouch L, Cautela J, Resseguier N, Pinto J, Ammar C, Gaubert M, et al.
Arch Cardiovasc Dis . 2019 Apr; 112(6-7):410-419. PMID: 31006624
Background: Iron deficiency (ID) is common in heart failure (HF), and is associated with unfavourable clinical outcomes. Although it is recommended to screen for ID in HF, there is no...
6.
Laine M, Lemesle G, Dabry T, Panagides V, Peyrol M, Paganelli F, et al.
Expert Opin Pharmacother . 2018 Dec; 20(3):295-304. PMID: 30513232
Introduction: Anticoagulant therapy is critical to prevent ischemic recurrences and complications in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). Unfractionated heparin (UFH), an injectable anticoagulant has several...
7.
Laine M, Dabry T, Combaret N, Motreff P, Puymirat E, Paganelli F, et al.
J Invasive Cardiol . 2018 Nov; 31(1):10-14. PMID: 30418164
Objectives: Early endothelialization of drug-eluting stent (DES) is a major challenge to reduce the risk of stent thrombosis and the duration of dual-antiplatelet therapy (DAPT) in high bleeding-risk patients. The...
8.
Maille B, Koutbi L, Resseguier N, Lemoine C, Thuny F, Peyrol M, et al.
Heart Vessels . 2018 Nov; 34(5):824-831. PMID: 30415372
Infections of cardiac implantable electronic devices (CIEDs) have increased over the past decade. However, the impact of the climate on CIED infections is unknown. To determine whether there is a...
9.
Peyrol M, Cautela J, Salaun E, Miola C, Franceschi F, Thuny F, et al.
Heart Lung Circ . 2018 Oct; 28(11):1683-1688. PMID: 30301672
Background: Left atrial appendage occlusion (LAAO) is increasingly used for stroke prevention in patients with atrial fibrillation who are considered unsuitable for a lifelong oral anticoagulant regimen. Recently, a single-centre...
10.
Koutbi L, Maille B, Peyrol M, Hourdain J, Salaun E, Deharo J, et al.
Pacing Clin Electrophysiol . 2018 Jun; 41(9):1071-1077. PMID: 29947109
Purpose: Ablation of premature ventricular complexes (PVCs) originating from left-sided papillary muscles is challenging. We tested a new approach by performing high-density mapping of PVC. Methods And Results: We used...